2024
DOI: 10.2339/politeknik.1094010
|View full text |Cite
|
Sign up to set email alerts
|

Mikroakışkan Çiplere Kök Hücre ve Doku Mühendisliği Perspektifinden Bakış

Abstract: Kolayca modifiye edilebilir ve pek çok çalışmaya entegre edilebilir özellikleriyle mikroakışkan sistemler son yıllarda araştırmacıların ilgi odağındadır. Mikroakışkan çipler sayesinde daha az solüsyon ve sürekli perfüzyon ile kontrollü ve optimize hücre kültürü çalışmaları yapılabilmektedir. Son yıllarda özellikle rejeneratif tıbbın ilgisini çeken kök hücrelerin tek başına veya diğer hücrelerle birlikte kültürlenmesi ve kullanılan kök hücrelerin istenilen yönde farklılaştırılması çip sistemlerinde sıklıkla çal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 104 publications
0
1
0
Order By: Relevance
“…Microfluidic technology involves precise fluid flow control in microchannels characterized by diverse geometries and sizes ranging from micrometers to millimeters. This technology holds significant potential across various domains, including drug screening, 1 drug discovery, 2 drug delivery, 3 4 5 6 7 8 9 biology sciences, 10 drug analysis, 11 12 and preclinical evaluation. 13 14 Notably, the application of microfluidics in drug delivery systems (DDSs), such as lipid nanoparticles (LNPs), has witnessed rapid advancement during the coronavirus disease 2019 (COVID-19) pandemic.…”
Section: Introductionmentioning
confidence: 99%
“…Microfluidic technology involves precise fluid flow control in microchannels characterized by diverse geometries and sizes ranging from micrometers to millimeters. This technology holds significant potential across various domains, including drug screening, 1 drug discovery, 2 drug delivery, 3 4 5 6 7 8 9 biology sciences, 10 drug analysis, 11 12 and preclinical evaluation. 13 14 Notably, the application of microfluidics in drug delivery systems (DDSs), such as lipid nanoparticles (LNPs), has witnessed rapid advancement during the coronavirus disease 2019 (COVID-19) pandemic.…”
Section: Introductionmentioning
confidence: 99%